India's NSE offers $160 million to settle with regulator, move ahead with IPO
The National Stock Exchange of India has offered to pay the country's markets regulator Rs13.88 billion ($160 million) to settle a legal dispute so it can proceed with a long-delayed initial public offering, three sources said.
The sum is set to be largest settlement made with the markets regulator in India's history.
India's biggest bourse and the world's most active derivatives exchange has been embroiled in litigation with the Securities and Exchange Board of India (SEBI) since 2019 when it was fined Rs11 billion for failing to provide equitable access to all its trading members.
They are negotiating an out-of-court settlement, according to two of the sources.
All three sources, who have direct knowledge of the discussions, were not authorised to speak to media and declined to be identified.
The regulator is likely to grant the exchange a certificate stating it has no objection to an IPO within three months, said one source.
"If all goes as per expected timelines, NSE's IPO could hit the markets before May next year," said another source.
NSE declined to comment. SEBI did not immediately reply to a Reuters request for comment.
The cash-rich Mumbai-headquarted NSE has been trying to list since 2016 to enable some of its biggest investors to exit.
But has been prevented by the regulator's investigations and then the fine. NSE challenged the penalty in court which ordered certain parts of SEBI's order to be set aside, which the regulator later appealed at the nation's top court.
Among NSE's largest investors are the Life Insurance Corporation of India with a 10.72% stake and the State Bank of India with 7.76%, while Morgan Stanley owns 1.58% and the Canada Pension Investment Plan Board has 1.60%.
Its main domestic rival, BSE Ltd, listed in 2017.
SEBI is conducting an inspection of the exchange's systems and processes before the no-objection certificate is issued, said two of the sources.
SEBI wrote to the NSE in February flagging concerns about the bourse's internal processes, including how management is appointed and remunerated, its failure to appoint a chairperson and technology shortfalls.
The settlement, if accepted by the regulator, will need the approval of India's top court, two of the sources said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Khaleej Times
6 hours ago
- Khaleej Times
India's NSE offers $160 million to settle with regulator, move ahead with IPO
The National Stock Exchange of India has offered to pay the country's markets regulator Rs13.88 billion ($160 million) to settle a legal dispute so it can proceed with a long-delayed initial public offering, three sources said. The sum is set to be largest settlement made with the markets regulator in India's history. India's biggest bourse and the world's most active derivatives exchange has been embroiled in litigation with the Securities and Exchange Board of India (SEBI) since 2019 when it was fined Rs11 billion for failing to provide equitable access to all its trading members. They are negotiating an out-of-court settlement, according to two of the sources. All three sources, who have direct knowledge of the discussions, were not authorised to speak to media and declined to be identified. The regulator is likely to grant the exchange a certificate stating it has no objection to an IPO within three months, said one source. "If all goes as per expected timelines, NSE's IPO could hit the markets before May next year," said another source. NSE declined to comment. SEBI did not immediately reply to a Reuters request for comment. The cash-rich Mumbai-headquarted NSE has been trying to list since 2016 to enable some of its biggest investors to exit. But has been prevented by the regulator's investigations and then the fine. NSE challenged the penalty in court which ordered certain parts of SEBI's order to be set aside, which the regulator later appealed at the nation's top court. Among NSE's largest investors are the Life Insurance Corporation of India with a 10.72% stake and the State Bank of India with 7.76%, while Morgan Stanley owns 1.58% and the Canada Pension Investment Plan Board has 1.60%. Its main domestic rival, BSE Ltd, listed in 2017. SEBI is conducting an inspection of the exchange's systems and processes before the no-objection certificate is issued, said two of the sources. SEBI wrote to the NSE in February flagging concerns about the bourse's internal processes, including how management is appointed and remunerated, its failure to appoint a chairperson and technology shortfalls. The settlement, if accepted by the regulator, will need the approval of India's top court, two of the sources said.
Khaleej Times
6 hours ago
- Khaleej Times
Vedanta Resources reports record $18.2 billion revenue and $5.5 billion EBITDA in FY25
Vedanta Resources Limited ('VRL'), the world's leading transition metals, critical minerals, energy, and technology company, has reported robust growth in revenue and EBITDA for FY25, driven by favourable commodity prices, higher premiums, and operational efficiencies. The company posted a record revenue of US$18.2 billion, up 6% year-on-year, and achieved its second-highest consolidated EBITDA of US$ 5.5 billion, marking a 16% increase from the previous year. The EBITDA margin rose to an industry-leading 36%. Free cash flow post-capex totalled US$ 1.0 billion, while cash and cash equivalents stood at US$ 2.6 billion. Return on capital employed (ROCE) remained strong at approximately 25%, underscoring disciplined and value-focused deployment across its portfolio. Commenting on the performance, Anil Agarwal, chairman of Vedanta Resources Limited, said: "The world around us is moving fast. There are big changes in geopolitics and geoeconomics. Some may view them as a challenge. We view them as opportunities." Looking ahead, he added: "For Vedanta, this is the right moment to transform itself into a natural resources, energy and technology company. Vedanta 2.0 will have a key role in each of the most crucial levers of the economy. We are also in the process of demerging our business verticals to create a pure play model, which is nimble and fine-tuned to even faster growth and unlocking of massive value." The company also made significant progress in deleveraging, reducing its net debt by US$1.2 billion to US$11.1 billion. This improved the net debt/EBITDA ratio to 2.0x from 2.6x the previous year. Reflecting its strengthened financial position, S&P Global raised VRL's credit rating by three notches to B+, while Fitch Ratings and Moody's also upgraded their ratings to B+ and B1, respectively. Operationally, Zinc India achieved record mined and refined metal production of 1,095 kt and 1,052 kt, respectively. Aluminium operations delivered record metal production of 2,422 kt and alumina production of 1,975 kt. Both businesses maintained cost leadership, ranking in the top quartile and top decile of the global cost curve, respectively. Vedanta's Indian subsidiary, Vedanta Limited, is currently undergoing a strategic demerger that will result in four independent, sector-focused, and globally scaled entities. The demerger was approved by shareholders and creditors with an overwhelming majority of over 99.5% voting in favour.
Zawya
9 hours ago
- Zawya
Specialized Medical Company announces the successful listing and commencement of trading On Saudi Exchange
Riyadh, Saudi Arabia: Specialized Medical Company ('Company' or 'SMC'), one of the leading healthcare providers in the Kingdom of Saudi Arabia ('Kingdom'), recognized as a center of excellence delivering comprehensive and integrated healthcare services across a wide range of specialties, announces the successful completion of its initial public offering (the 'IPO' or the 'Offering'). The Company is now trading under the ticker symbol: 4019. Bassam Chahine, CEO at Specialized Medical Company commented: 'Today marks a major milestone in SMC's journey. Our successful listing on the Saudi Exchange is a reflection of the market's strong confidence in our equity story and our commitment to delivering high-quality, accessible, and digitally enabled healthcare services across the Kingdom. The overwhelming demand from both institutional and retail investors reinforces the strength of our operating model, our ambitious growth roadmap, and our role in advancing the Kingdom's Vision 2030 healthcare transformation. I would like to thank our employees, partners, and shareholders for their trust and support, we are proud to welcome new investors to join us as we enter this next chapter of growth.' The Offering consisted of 75,000,000 ordinary shares (the 'Offer Shares') with 80% of the Offer Shares allocated to Institutional Investors (the 'Participating Parties'). The orders recorded during the institutional book-building exceeded SAR 121.3 billion (approximately more than USD 32.4 billion), representing a coverage of 64.7 times. The number of shares that were allocated to the Individual Investors tranche was 15,000,000 Offer Shares, representing 20% of the total Offer Shares. The Offering saw 317,820 individual investors place orders totaling SAR 542.2 million, reflecting a subscription coverage of 1.45 times for this tranche. The Final Offer Price was set at SAR 25.00 per share, which is at the top end of the previously announced price range for the IPO, with the Company successfully raising gross proceeds of SAR 1,875 million (USD 500 million) with an implied market capitalization at a listing of SAR 6,250 million (USD 1,667 million).
